{
    "xml": "<topic id=\"PHP2399\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/phenelzine\" basename=\"phenelzine\" title=\"PHENELZINE\">\n<title>PHENELZINE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_259\" namespace=\"/interactions/list-of-drug-interactions/antidepressants/maois/phenelzine\">Phenelzine</xref>\n</p>\n<data name=\"vtmid\">9500005</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_272538066\" title=\"Monoamine-oxidase A and B inhibitors (irreversible)\">Monoamine-oxidase A and B inhibitors (irreversible)</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34557\" title=\"MONOAMINE-OXIDASE INHIBITORS\" namespace=\"/drug-classes/monoamine-oxidase-inhibitors\">MONOAMINE-OXIDASE INHIBITORS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP36089\" outputclass=\"indicationsAndDose\" rev=\"1.49\" parent=\"/drugs/phenelzine\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Depressive illness</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 15&#8239;mg 3 times a day, response is usually seen within first week; dose may be increased if necessary after 2 weeks if reponse is not evident, increased if necessary to 15&#8239;mg 4 times a day, doses up to 30&#8239;mg three times a day may be used in hospital patients, then reduced to 15&#8239;mg once daily on alternate days, response may not become apparent for up to 4 weeks, once satisfactory response has been acheived, reduce dose gradually to lowest suitable maintenance dose (15&#8239;mg on alternate days may be adequate).</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36098\" outputclass=\"breastFeeding\" parent=\"/drugs/phenelzine\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36091\" outputclass=\"hepaticImpairment\" parent=\"/drugs/phenelzine\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid in hepatic impairment or if abnormal liver function tests.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36071\" outputclass=\"lessSuitableForPrescribing\" rev=\"1.11\" parent=\"/drugs/phenelzine\">\n<title>Less suitable for prescribing</title>\n<body>\n<section>\n<sectiondiv>\n<p>Less suitable for prescribing.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP2399-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/phenelzine\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77953\" title=\"Tablet\" namespace=\"/drugs/phenelzine/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78258\" namespace=\"/treatment-summaries/antidepressant-drugs\" title=\"Antidepressant drugs\" count=\"2\" rel=\"backlink\">Antidepressant drugs</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_259\" namespace=\"/interactions/list-of-drug-interactions/antidepressants/maois/phenelzine\" title=\"Phenelzine\" count=\"1\" rel=\"link\">Phenelzine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34557\" namespace=\"/drug-classes/monoamine-oxidase-inhibitors\" title=\"MONOAMINE-OXIDASE INHIBITORS\" count=\"1\" rel=\"link\">MONOAMINE-OXIDASE INHIBITORS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77953\" namespace=\"/drugs/phenelzine/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP2399",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/phenelzine",
    "basename": "phenelzine",
    "title": "PHENELZINE",
    "interactants": [
        {
            "id": "bnf_int_259",
            "label": "Phenelzine"
        }
    ],
    "vtmid": "9500005",
    "drugClassification": [
        "Monoamine-oxidase A and B inhibitors (irreversible)"
    ],
    "inheritsFromClass": [
        "MONOAMINE-OXIDASE INHIBITORS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Depressive illness",
                        "html": "Depressive illness"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 15 mg 3 times a day, response is usually seen within first week; dose may be increased if necessary after 2 weeks if reponse is not evident, increased if necessary to 15 mg 4 times a day, doses up to 30 mg three times a day may be used in hospital patients, then reduced to 15 mg once daily on alternate days, response may not become apparent for up to 4 weeks, once satisfactory response has been acheived, reduce dose gradually to lowest suitable maintenance dose (15 mg on alternate days may be adequate).",
                        "html": "<p>Initially 15&#8239;mg 3 times a day, response is usually seen within first week; dose may be increased if necessary after 2 weeks if reponse is not evident, increased if necessary to 15&#8239;mg 4 times a day, doses up to 30&#8239;mg three times a day may be used in hospital patients, then reduced to 15&#8239;mg once daily on alternate days, response may not become apparent for up to 4 weeks, once satisfactory response has been acheived, reduce dose gradually to lowest suitable maintenance dose (15&#8239;mg on alternate days may be adequate).</p>"
                    }
                ]
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid&#8212;no information available.",
                "html": "<p>Avoid&#8212;no information available.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid in hepatic impairment or if abnormal liver function tests.",
                "html": "<p>Avoid in hepatic impairment or if abnormal liver function tests.</p>"
            }
        ]
    },
    "lessSuitableForPrescribing": {
        "lessSuitableForPrescribing": [
            {
                "type": "lessSuitableForPrescribing",
                "textContent": "Less suitable for prescribing.",
                "html": "<p>Less suitable for prescribing.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77953",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78258",
                "label": "Antidepressant drugs",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_259",
                "label": "Phenelzine",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34557",
                "label": "MONOAMINE-OXIDASE INHIBITORS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77953",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}